Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MiR-696 Regulates C2C12 Cell Proliferation and Differentiation by Targeting CNTFRα.

International journal of biological sciences·2017
Same author

A novel dual-wavelength laser stimulator to elicit transient and tonic nociceptive stimulation.

Lasers in medical science·2017
Same author

Finite element method simulating temperature distribution in skin induced by 980-nm pulsed laser based on pain stimulation.

Lasers in medical science·2017
Same author

Analysis of the Factors That Could Predict Segmental Range of Motion After Cervical Artificial Disk Replacement: A 7-Year Follow-up Study.

Clinical spine surgery·2017
Same author

Rnf138 deficiency promotes apoptosis of spermatogonia in juvenile male mice.

Cell death & disease·2017
Same author

Performance of pfHRP2 versus pLDH antigen rapid diagnostic tests for the detection of <i>Plasmodium falciparum</i>: a systematic review and meta-analysis.

Archives of medical science : AMS·2017

Related Experiment Videos

SSGraphDTI: A Drug-Target Interaction Prediction Method Integrated Structural and Dynamic Systemic Biology

Haotian Guan, Tian Bai, Jingtong Zhao

    IEEE Journal of Biomedical and Health Informatics
    |June 5, 2025
    PubMed
    Summary

    This study introduces SSGraphDTI, a novel computational model for predicting drug-target interactions (DTIs). By integrating structural and systemic biological data, it enhances DTI prediction accuracy and addresses the "cold-start problem" in drug discovery.

    Related Experiment Videos

    Area of Science:

    • Computational chemistry
    • Bioinformatics
    • Drug discovery

    Background:

    • Drug-Target Interaction (DTI) prediction is vital for pharmaceutical development but faces challenges with expensive experiments and unreliable computational methods.
    • Integrating drug molecular networks offers valuable information for improving DTI prediction accuracy.

    Purpose of the Study:

    • To propose and evaluate SSGraphDTI, a novel model that integrates structural and systemic biological attributes for enhanced DTI prediction.
    • To address the limitations of current DTI prediction methods, including the
    • cold-start problem
    • and performance with limited data.

    Main Methods:

    • Extracted drug structural attributes using convolutional neural networks from Simplified Molecular Input Line Entry System (SMILES).
    • Extracted target structural attributes from amino acid sequences using convolutional neural networks.
    • Obtained systemic biological attributes via graph representation learning on a dynamically constructed heterogeneous drug-target interaction network.

    Main Results:

    • SSGraphDTI achieved approximately 1.0% improvement across five metrics on the Dataset_DrugBank compared to recent methods.
    • The model effectively addresses the "cold-start problem" by utilizing solely structural data.
    • Maintained strong predictive performance even with limited data by extracting systemic attributes from DTI networks.

    Conclusions:

    • Integrating both structural and systemic information significantly enhances DTI prediction accuracy.
    • SSGraphDTI offers a promising approach for efficient and accurate drug discovery, particularly in scenarios with limited interaction data.